Clinical trials are changing rapidly. As one of the most expensive parts of the drug development process we will look into how data driven technologies can bring down cost, reduce dropouts and represent real world data.
Martin Preusse, Chief Executive Officer, Kaiser & Preusse
Pandu Raharja-Liu, Co-Founder and Chief Technology Officer, Panakeia Technologies Limited
Derek Burke, UK&I Regional Sales Manager, WekaIO
Siobhan Southam, Digital Experimental Cancer Medicine Team - Strategic Engagement Leader, AstraZeneca
Letizia Gionfrida, Chief Executive Officer, Arthronica
Miron Tokarski, Chief Executive Officer, Genomtec
Stephan Cichos, Principal Data Manager, Bayer